Infographic title: HPV Vaccine: Weighing the Benefits and Costs Persistent human papillomavirus (HPV) infections lasting for more than six months in the vaginal epithelium can lead to the development of precancerous lesions, which if left untreated, may progress to invasive cervical cancer.1 Early HPV vaccination and timely screening are essential in helping prevent HPV-related diseases and cancers.2 In India, there is a lack of comprehensive economic evaluations, with previous studies primarily focusing on the value for money of bivalent vaccines from a healthcare perspective.1 Here we have graphically summarized a study that aims to conduct a cost-effectiveness analysis of all available HPV vaccines in India from both, the societal and hospital perspectives .1